The company’s total income has increased by 17.7 per cent to Rs.443.1 crore for the quarter under review from Rs.376.3 crore for the corresponding quarter of the previous year.
The pharma company reported 20.3 per cent rise in its net profit at Rs. 99.9 crore for the quarter ended September 30, 2015 as compared to Rs. 83 crore for the same quarter in the previous year. The company’s total income has increased by 17.7 per cent to Rs. 443.1 crore for the quarter under review from Rs.376.3 crore for the corresponding quarter of the previous year.
On a standalone basis, the company reported 20.4 per cent rise in its net profit at Rs.94.7 crore for the quarter ended September 30, 2015 as compared to Rs.78.63 crore for the same quarter in the previous year. The company’s total income has increased by 16.7 per cent to Rs.412.5 crore for the quarter under review from Rs.353.2 crore for the corresponding quarter of the previous year.
No comments:
Post a Comment